Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16009-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16009-1-AP, RRID:AB_2164314
- Product name
- PLA2G12A antibody
- Antibody type
- Polyclonal
- Description
- PLA2G12A antibody (Cat. #16009-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.
Quantitative trait locus mapping in mice identifies phospholipase Pla2g12a as novel atherosclerosis modifier.
The expression of groups IIE and V phospholipase A2 is associated with an increased expression of osteogenic molecules in human calcified aortic valves.
Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction.
Li T, Yao W
Experimental and therapeutic medicine 2018 Nov;16(5):4119-4123
Experimental and therapeutic medicine 2018 Nov;16(5):4119-4123
Quantitative trait locus mapping in mice identifies phospholipase Pla2g12a as novel atherosclerosis modifier.
Nicolaou A, Northoff BH, Sass K, Ernst J, Kohlmaier A, Krohn K, Wolfrum C, Teupser D, Holdt LM
Atherosclerosis 2017 Oct;265:197-206
Atherosclerosis 2017 Oct;265:197-206
The expression of groups IIE and V phospholipase A2 is associated with an increased expression of osteogenic molecules in human calcified aortic valves.
Suzuki K, Takahashi S, Watanabe K, Fujioka D, Nakamura T, Obata JE, Kawabata K, Katoh R, Matsumoto M, Kugiyama K
Journal of atherosclerosis and thrombosis 2014;21(12):1308-25
Journal of atherosclerosis and thrombosis 2014;21(12):1308-25
Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction.
Takahashi S, Suzuki K, Watanabe Y, Watanabe K, Fujioka D, Nakamura T, Obata JE, Kawabata K, Mishina H, Kugiyama K
International journal of cardiology 2013 Oct 9;168(4):4214-21
International journal of cardiology 2013 Oct 9;168(4):4214-21
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 16009-1-AP(PLA2G12A antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 16009-1-AP(PLA2G12A antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PLA2G12A antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PLA2G12A. This antibody recognizes human,mouse,rat antigen. The PLA2G12A antibody has been validated for the following applications: ELISA, WB, IHC analysis.
